These compounds may interact with:
Methionine aminopeptidase 2
Potentially involved in: carcinoma; acute quadriplegic myopathy; astrocytic glioma; breast cancer; glioblastoma; group 3 medulloblastoma; intraductal papillary-mucinous adenoma (ipma); intraductal papillary-mucinous carcinoma (ipmc); medulloblastoma, large-cell; multiple myeloma; oligodendroglioma; osteosarcoma; ovarian cancer; pancreatic ductal adenocarcinoma liver metastasis; pediatric high grade glioma; posterior fossa group a ependymoma; primitive neuroectodermal tumor; psoriasis; rheumatoid arthritis; tuberculosis and treatment for 6 months
Disease data sourced from Pharos.